Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol MR lymphography as preoperative examination for lymphaticovenular anastomosis in lymphedema
jRCTs041220015Phase 2Completed
- Start
- Jun 2022
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gadobutrol in lymphedema. Primary endpoint: Safety of gadobutrol MR lymphangiography. Started Jun 2022; status: completed.
02
Drugs
gadobutrol
03
Conditions
lymphedema
Beyond the preview
Go deeper on jRCTs041220015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220015.